CASTAGNOLI, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 6.942
AS - Asia 3.711
EU - Europa 2.473
SA - Sud America 832
Continente sconosciuto - Info sul continente non disponibili 259
AF - Africa 151
OC - Oceania 13
Totale 14.381
Nazione #
US - Stati Uniti d'America 6.642
CN - Cina 1.133
SG - Singapore 1.070
BR - Brasile 631
IE - Irlanda 598
HK - Hong Kong 576
VN - Vietnam 386
RU - Federazione Russa 358
IT - Italia 330
DE - Germania 278
FR - Francia 196
FI - Finlandia 168
CA - Canada 157
IN - India 150
GB - Regno Unito 149
SE - Svezia 91
AR - Argentina 79
BD - Bangladesh 77
UA - Ucraina 62
ZA - Sudafrica 60
MX - Messico 49
PL - Polonia 47
NL - Olanda 46
JP - Giappone 38
IQ - Iraq 37
ES - Italia 36
PK - Pakistan 36
EC - Ecuador 31
AT - Austria 30
CO - Colombia 29
ID - Indonesia 27
TR - Turchia 27
PH - Filippine 24
CR - Costa Rica 17
MA - Marocco 17
VE - Venezuela 17
UZ - Uzbekistan 16
BE - Belgio 15
IL - Israele 14
JM - Giamaica 14
KE - Kenya 14
SA - Arabia Saudita 14
EG - Egitto 13
TN - Tunisia 13
AU - Australia 12
HN - Honduras 10
MY - Malesia 10
PY - Paraguay 10
TT - Trinidad e Tobago 10
AZ - Azerbaigian 9
GR - Grecia 9
LT - Lituania 9
PE - Perù 9
CH - Svizzera 8
CL - Cile 8
GT - Guatemala 8
MU - Mauritius 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
UY - Uruguay 7
DZ - Algeria 6
EE - Estonia 6
JO - Giordania 6
NI - Nicaragua 6
CW - ???statistics.table.value.countryCode.CW??? 5
CZ - Repubblica Ceca 5
GE - Georgia 5
KG - Kirghizistan 5
KR - Corea 5
LV - Lettonia 5
OM - Oman 5
PA - Panama 5
PR - Porto Rico 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
EU - Europa 4
GP - Guadalupe 4
KZ - Kazakistan 4
LB - Libano 4
NP - Nepal 4
PT - Portogallo 4
SV - El Salvador 4
TH - Thailandia 4
AM - Armenia 3
BB - Barbados 3
BG - Bulgaria 3
DK - Danimarca 3
GY - Guiana 3
IR - Iran 3
PS - Palestinian Territory 3
RO - Romania 3
AO - Angola 2
BW - Botswana 2
BY - Bielorussia 2
CY - Cipro 2
GA - Gabon 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
Totale 14.104
Città #
San Jose 845
Ashburn 702
Dublin 593
Singapore 569
Hong Kong 567
Dallas 506
Chandler 492
Council Bluffs 465
Beijing 313
Boardman 175
Lauterbourg 159
Los Angeles 157
Ho Chi Minh City 152
Princeton 128
Lawrence 120
New York 114
Medford 106
Helsinki 102
Jacksonville 101
Munich 88
Nanjing 86
Hanoi 84
Redondo Beach 84
Santa Clara 76
Wilmington 75
São Paulo 69
Buffalo 66
Shanghai 61
Moscow 54
Ann Arbor 50
Columbus 50
Toronto 50
Chicago 48
Johannesburg 44
Atlanta 42
Seattle 42
Milan 41
Warsaw 40
Nuremberg 39
The Dalles 38
Montreal 37
Orem 36
Turku 36
Changsha 35
Brooklyn 34
Nanchang 34
Frankfurt am Main 33
Tokyo 33
Phoenix 31
San Francisco 29
Chennai 28
Denver 28
Shenyang 27
Washington 27
Rio de Janeiro 26
Hangzhou 25
Jiaxing 22
Tianjin 21
Da Nang 20
Hebei 20
London 20
Rome 20
Boston 19
Mexico City 18
Stockholm 18
Brasília 17
Fairfield 17
Haiphong 17
Houston 17
Falkenstein 16
Brussels 15
Dhaka 15
Manchester 15
Belo Horizonte 14
Memphis 14
Naples 14
Pavia 14
Pune 14
Tashkent 14
Baghdad 13
Des Moines 13
Mumbai 13
Nairobi 13
North Bergen 13
Amsterdam 12
Guangzhou 12
Hyderabad 12
Poplar 12
Woodbridge 12
Norwalk 11
Paris 11
Redwood City 11
Florence 10
Guayaquil 10
Kingston 10
New Delhi 10
Philadelphia 10
Quito 10
San José 10
Vienna 10
Totale 8.721
Nome #
A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: A three-center, assessor blinded trial 228
Immunomodulation in pediatric asthma 199
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies 197
Impact of passive smoke and/or atopy on adenoid immunoglobulin production in children 169
Clinical features of pediatric chronic urticaria: A single-center analysis 158
ATOPIC DERMATITIS: IS THERE A ROLE FOR PROBIOTICS? 136
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 136
Allergy work-up in a child undergoing general anesthesia, with suspected latex allergy 131
Asthma endotyping and biomarkers in childhood asthma 130
X-Linked Hypohidrotic Ectodermal Dysplasia: New Features and a Novel EDA Gene Mutation 130
An update on biological therapies for pediatric allergic diseases 129
Amiodarone hypersensitivity reaction and basophil activation test 127
Allergic reaction to oral Furosemide 125
From IgE to clinical trials of allergic rhinitis 125
An immune-based biomarker signature is associated with mortality in COVID-19 patients. 125
Allergen immunotherapy for IgE-mediated food allergy: There is a measure in everything to a proper proportion of therapy 120
Allergy and covid-19 120
Allergy and asthma in children and adolescents during the COVID outbreak: What we know and how we could prevent allergy and asthma flares 119
Clinical and Epidemiological Features of Pediatric Patients with COVID-19 in a Tertiary Pediatric Hospital 118
Allergen immunotherapy in children and adolescents with respiratory diseases 118
Current and emerging biologic therapies for allergic rhinitis and chronic rhinosinusitis 117
Omalizumab for the treatment of chronic idiopathic/spontaneous urticaria in children 115
Selective IgM Deficiency: Evidence, Controversies, and Gaps 114
Biologic Use in Allergic and Asthmatic Children and Adolescents during the COVID-19 Pandemic 114
The role of upper airway pathology as a co-morbidity in severe asthma 113
Predicting challenge outcomes in children: role of histamine levels 111
Additional Concerns Regarding Children With Coronavirus Disease 2019-Reply 111
An update on anti-ige therapy in pediatric respiratory diseases 110
Novel Approaches to the Study of Neonatal Infections 110
Current recommendations and emerging options for the treatment of allergic rhinitis. 108
Eosinophilic gastrointestinal disorders in children: An Italian single-center experience 106
Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic 103
COVID-19 in the pediatric population admitted to a tertiary referral hospital in Northern Italy: Preliminary clinical data 103
Clinical and immunological phenotypes of selective IgM deficiency in children: Results from a multicenter study 102
Behavioral issues and quality of life in children with eosinophilic esophagitis 102
A compilation answering 50 questions on monkeypox virus and the current monkeypox outbreak 101
Egg allergy: diagnosis and benefit of basophilic activation test 101
An asymptomatic mediastinal cyst in a young child: Case report and summary of the literature 100
SARS-CoV-2 infection in pediatric population 100
Mitochondrial Complex I Deficiency: Unraveling the Relevance of NDUFAF1 in Pediatric Hypertrophic Cardiomyopathy 99
An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma 99
Timely adaptation of a pediatric unit to COVID-19 emergency in Northern Italy: The experience of Fondazione IRCCS Policlinico San Matteo in Pavia 99
Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19 99
Alpha-Gal Syndrome in Children: Peculiarities of a “Tick-Borne” Allergic Disease 98
Biomarkers of immunotherapy response in patients with allergic rhinitis 97
Association between treatment awareness and uncontrolled asthma in adolescents 96
Off-label treatment with Cyclosporine A in a child with severe atopic dermatitis 96
Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents 95
Quantitation of T Cell Repertoire Diversity Following Treatment for SCID 95
COVID-19 and autoimmune diseases: is there a connection? 94
The use of basophil activation test to diagnose egg-allergy in children 94
Omalizumab in children. 94
Protocols for drug allergy desensitization in children 93
Novel biologics for the treatment of pediatric severe asthma 92
Characterization of Gut Inflammation and Autoimmunity in Mice Carrying Rag1 Hypomorphic Mutations 90
Admission rates for respiratory diseases during the covid-19 pandemic: The experience of the pediatric clinic in Pavia 88
Clinical Heterogeneity of Early-Onset Autoimmune Gastritis: From the Evidence to a Pediatric Tailored Algorithm 87
Eosinophilic Gastrointestinal Diseases in Inborn Errors of Immunity 86
Hymenoptera venom allergy among children in Italy: time for pediatricians to take action 86
Food allergies: Current and future treatments 85
Defining intestinal tissue pathology and microbiota/metabolome composition in mice carrying Rag1 hypomorphic mutations 85
Drug allergy: epidemiology of a cohort of pediatric patient 84
Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives 84
Towards precision medicine in pediatric severe asthma: An update on current and emerging biomarkers 82
Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C 82
Hymenoptera venom allergy in children 81
Pediatric COVID-19 – a review 80
Omalizumab in children with severe allergic asthma: The Italian real- life experience 80
Skin tests are important in children with β-lactam hypersensitivity, but may be reduced in number 80
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives 79
Comprehensive genetic results for primary immunodeficiency disorders in a highly consanguineous population 78
Low T-Cell Receptor beta (TRB) Repertoire Diversity Early Post-Transplant for Severe Combined Immunodeficiency (SCID) Predicts Subsequent Failure of Immune Reconstitution 78
Inborn errors of immunity with atopic phenotypes in the allergy and immunology clinic: a practical review 78
CAR-T Cell Therapy in Autoimmune Setting: A New Appealing Approach Extendable to Allergy? 77
Personalized therapies for the treatment of allergic rhinitis 77
Immunological basis of virus-host interaction in COVID-19 76
Type-2 inflammatory mediators as targets for precision medicine in children 76
Pediatric COVID-19 – a review 76
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review 75
Severe uncontrolled asthma in children: Practical approach on diagnosis and management 75
NGS Reveals Repertoire Restriction of Treg Cells in APDS1 Patients 73
Activated phosphoinositide 3-dinase delta syndrome (APDS): An update 73
Management of severe asthma in children: current insights and future directions 72
The discovery and development of omalizumab for the treatment of asthma 71
Emerging drugs for the treatment of perennial allergic rhinitis 71
Inborn Errors of Immunity With Immune Dysregulation: From Bench to Bedside 71
Complete Absence of CD3γ Protein Expression Is Responsible for Combined Immunodeficiency with Autoimmunity Rather than SCID 71
Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection 70
Urticaria in childhood 70
Human inborn errors of immunity caused by defects of receptor and proteins of cellular membrane 70
Updates on new monogenic inborn errors of immunity 70
Eosinophilic esophagitis after congenital diaphragmatic hernia 68
Anxiety and depression in adolescents with asthma: a study in clinical practice 68
New approaches for identifying and testing potential new anti-asthma agents 67
Low T-Cell Receptor β ( ) Repertoire Diversity Early Post-Transplant for Severe Combined Immunodeficiency (SCID) Predicts Subsequent Failure of Immune Reconstitution 67
Identification of gut inflammation and autoimmunity in murine models carrying Rag1 hypomorphic mutations 66
Epidemiology of rare allergic diseases in children 66
COVID-19 and Inborn Errors of Immunity 65
Cysteine and hydrophobic residues in CDR3 serve as distinct T-cell self-reactivity indices 65
Applying the new guidelines to asthma management in children 65
Totale 9.805
Categoria #
all - tutte 73.001
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.001


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022571 0 0 0 3 17 44 4 15 33 96 75 284
2022/20231.529 176 104 32 107 95 152 1 84 696 6 59 17
2023/2024776 76 140 52 45 64 192 48 44 6 51 38 20
2024/20252.478 36 185 57 64 49 91 220 120 577 121 351 607
2025/20266.117 517 459 729 673 765 254 1.127 240 503 359 299 192
2026/20272.034 215 372 520 927 0 0 0 0 0 0 0 0
Totale 14.381